Table 3.
Relative Risks (RR) and 95% confidence intervals (CI) for the association between IRS-1 Gly972Arg variant and prostate cancer
| Cases, n | RR (95% CI) | |
|---|---|---|
|
| ||
| All prostate cancer | ||
| GG | 489 | 1.0 (Ref) |
| GA/AA | 75 | 1.1 (0.8, 1.5) |
| Tumor stage | ||
| A/B | ||
| GG | 266 | 1.00 |
| GA/AA | 37 | 0.9 (0.6, 1.4) |
| C, D or lethal | ||
| GG | 188 | 1.00 |
| GA/AA | 31 1.3 | (0.8, 2.3) |